Risks and benefits of sentinel lymph node evaluation in the management of endometrial intraepithelial neoplasia

References

• Woods P. Worldwide cancer data [Internet]. WCRF International. 2022 [cited 2024 Jan 24]. Available from: https://www.wcrf.org/cancer-trends/worldwide-cancer-data/
   Google Scholar
• Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. doi: 10.3322/caac.21763
   PubMed Web of Science ®Google Scholar
• Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer. Lancet. 2022;399(10333):1412–1428. doi: 10.1016/S0140-6736(22)00323-3
   PubMed Web of Science ®Google Scholar
• Owings RA, Quick CM. Endometrial intraepithelial neoplasia. Arch Pathol Lab Med. 2014;138(4):484–491. doi: 10.5858/arpa.2012-0709-RA
   PubMed Web of Science ®Google Scholar
• Cancer facts & figures 2023 [Internet]. [cited 2024 Mar 27]. Available from: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html
   Google Scholar
• Reed SD, Newton KM, Clinton WL, et al. Incidence of endometrial hyperplasia. Am J Obstet Gynecol. 2009;200(6):678.e1–6. doi: 10.1016/j.ajog.2009.02.032
   PubMed Web of Science ®Google Scholar
• Zhao J, Hu Y, Zhao Y, et al. Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments. BMC Womens Health [Internet]. 2021;21. doi: 10.1186/s12905-021-01452-9
   Web of Science ®Google Scholar
• Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer. 2006;106(4):812–819. doi: 10.1002/cncr.21650
   PubMed Web of Science ®Google Scholar
• SGO endorses ACOG publication “Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia” [Internet]. Society of gynecologic oncology. 2023 [cited 2023 Nov 22]. Available from: https://www.sgo.org/resources/sgo-endorses-acog-publication-management-of-endometrial-intraepithelial-neoplasia-or-atypical-endometrial-hyperplasia/
   Google Scholar
• Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia [Internet]. [cited 2023 Nov 22]. Available from: https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2023/09/management-of-endometrial-intraepithelial-neoplasia-or-atypical-endometrial-hyperplasia
   Google Scholar
• Abu-Rustum NR, Yashar CM, Bradley K, et al. NCCN Guidelines® insights: uterine neoplasms, version 3.2021: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2021;19(8):888–895. doi: 10.6004/jnccn.2021.0038
   PubMedGoogle Scholar
• Cancer of the endometrium - cancer stat facts [Internet]. SEER; [cited 2024 Jan 31]. Available from: https://seer.cancer.gov/statfacts/html/corp.html
   Google Scholar
• Ballester M, Dubernard G, Lécuru F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12(5):469–476. doi: 10.1016/S1470-2045(11)70070-5
   PubMed Web of Science ®Google Scholar
• Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(5):459–476.e10. doi: 10.1016/j.ajog.2016.11.1033
   PubMed Web of Science ®Google Scholar
• Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 2017;18(3):384–392. doi: 10.1016/S1470-2045(17)30068-2
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(6):691–722. doi: 10.6004/jnccn.2022.0030
   PubMed Web of Science ®Google Scholar
• Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer. 1987;60:2035–2041.
   PubMed Web of Science ®Google Scholar
• Helgers RJA, Winkens B, Slangen BFM, et al. Lymphedema and post-operative complications after sentinel lymph node biopsy versus lymphadenectomy in endometrial carcinomas—A systematic review and meta-analysis. J Clin Med. 2020;10(1):120. doi: 10.3390/jcm10010120
   PubMed Web of Science ®Google Scholar
• Frost JA, Webster KE, Bryant A, et al. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2017[cited 2017 Oct 2];1010):CD007585. doi: 10.1002/14651858.CD007585.pub4
   PubMed Web of Science ®Google Scholar
• Hsu Y-Y, Liu C-Y, Ho C-L, et al. Determinants of quality of life related to lower limb lymphedema in women with gynecological cancer surgery. Asia Pac J Oncol Nurs. 2023;10(1):100153. doi: 10.1016/j.apjon.2022.100153
   PubMed Web of Science ®Google Scholar
• Carter J, Huang HQ, Armer J, et al. GOG 244 - the lymphedema and gynecologic cancer (LeG) study: the impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecol Oncol. 2021;160(1):244–251. doi: 10.1016/j.ygyno.2020.10.023
   PubMed Web of Science ®Google Scholar
• Mariani A, Webb MJ, Keeney GL, et al. Low-risk corpus cancer: is lymphadenectomy or r adiotherapy necessary? Am J Obstet Gynecol. 2000;182(6):1506–1519. doi: 10.1067/mob.2000.107335
   PubMed Web of Science ®Google Scholar
• Hamilton CA, Pothuri B, Arend RC, et al. Endometrial cancer: a society of gynecologic oncology evidence-based review and recommendations. Gynecol Oncol. 2021;160(3):817–826. doi: 10.1016/j.ygyno.2020.12.021
   PubMed Web of Science ®Google Scholar
• Kilts TP, Glaser GE, Langstraat CL, et al. Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer. Gynecol Oncol. 2019;155(1):21–26. doi: 10.1016/j.ygyno.2019.08.005
   PubMed Web of Science ®Google Scholar
• Milam MR, Java J, Walker JL, et al. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol. 2012;119(2, Part 1):286–292. doi: 10.1097/AOG.0b013e318240de51
   PubMed Web of Science ®Google Scholar
• SGO clinical practice statement: the role of sentinel lymph node mapping in endometrial cancer (SGO, November 2015) [Internet]. Society of gynecologic oncology. 2015 [cited 2024 Feb 1]. Available from: https://www.sgo.org/resources/the-role-of-sentinel-lymph-node-mapping-in-endometrial-cancer/
   Google Scholar
• Khoury-Collado F, St. Clair C, Abu-Rustum NR. Sentinel lymph node mapping in endometrial cancer: an update. Oncologist. 2016;21(4):461–466. doi: 10.1634/theoncologist.2015-0473
   PubMed Web of Science ®Google Scholar
• Matsuo K, Vallejo A, Rau AR, et al. Cancer stage-shifting with sentinel lymph node biopsy in low-grade endometrial cancer. Ann Surg Oncol. 2023;30(6):3191–3193. doi: 10.1245/s10434-023-13310-z
   PubMed Web of Science ®Google Scholar
• Bogani G, Giannini A, Vizza E, et al. Sentinel node mapping in endometrial cancer. J Gynecol Oncol. 2024;35(1):e29. doi: 10.3802/jgo.2024.35.e29
   PubMed Web of Science ®Google Scholar
• Matsuo K, Klar M, Nusbaum DJ, et al. Utilization and outcomes of sentinel lymph node biopsy for early endometrial cancer. Obstet Gynecol. 2022;139(5):809–820. doi: 10.1097/AOG.0000000000004733
   PubMed Web of Science ®Google Scholar
• Mueller JJ, Rios-Doria E, Park KJ, et al. Sentinel lymph node mapping in patients with endometrial hyperplasia: a practice to preserve or abandon? Gynecol Oncol. 2023;168:1–7. doi: 10.1016/j.ygyno.2022.10.017
   PubMed Web of Science ®Google Scholar
• Matanes E, Amajoud Z, Kogan L, et al. Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia? Gynecol Oncol. 2023;168:107–113. doi: 10.1016/j.ygyno.2022.10.023
   PubMed Web of Science ®Google Scholar
• Sullivan MW, Philp L, Kanbergs AN, et al. Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions. Gynecol Oncol. 2021;162(3):613–618. doi: 10.1016/j.ygyno.2021.07.004
   PubMed Web of Science ®Google Scholar
• Shalowitz DI, Goodwin A, Schoenbachler N. Does surgical treatment of atypical endometrial hyperplasia require referral to a gynecologic oncologist? Am J Obstet Gynecol. 2019;220(5):460–464. doi: 10.1016/j.ajog.2018.12.010
   PubMed Web of Science ®Google Scholar
• Smith BQ, Boone JD, Thomas ED, et al. Impact of consistent intraoperative assessment on predicting tumor size, myometrial invasion, and cervical involvement: results from an observational cohort. Gynecol Oncol. 2017;145:192. doi: 10.1016/j.ygyno.2017.03.438
   PubMed Web of Science ®Google Scholar
• Bourdel N, Chauvet P, Tognazza E, et al. Sampling in atypical endometrial hyperplasia: which method results in the lowest underestimation of endometrial cancer? A systematic review and meta-analysis. J Minim Invasive Gynecol. 2016;23(5):692–701. doi: 10.1016/j.jmig.2016.03.017
   PubMed Web of Science ®Google Scholar
• Leite S, Chen YS, Walker A, et al. Role of sentinel lymph node evaluation during hysterectomy for preoperative pathology diagnosis of endometrial intraepithelial neoplasia in a community hospital setting. Gynecol Oncol. 2024;184:83–88. doi: 10.1016/j.ygyno.2024.01.026
   PubMed Web of Science ®Google Scholar
• Dioun S, Chen L, Melamed A, et al. Uptake and outcomes of sentinel lymph node mapping in women with atypical endometrial hyperplasia. Obstet Gynecol. 2021;137(5):924–934. doi: 10.1097/AOG.0000000000004352
   PubMed Web of Science ®Google Scholar
• Matsuo K, Violette CJ, Tavakoli A, et al. Increasing utilization of surgical nodal evaluation at hysterectomy for endometrial hyperplasia. Obstet Gynecol. 2022;139(6):1152–1154. doi: 10.1097/AOG.0000000000004796
   PubMed Web of Science ®Google Scholar
• Matsuo K, Ciesielski KM, Mandelbaum RS, et al. Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting. Surg Endosc. 2023;37(8):6163–6171. doi: 10.1007/s00464-023-10081-2
   PubMed Web of Science ®Google Scholar
• Vieira-Serna S, Peralta J, Viveros-Carreño D, et al. Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis. Int J Gynecol Cancer. 2023;ijgc–2023–004936(1):66–72. doi: 10.1136/ijgc-2023-004936
   Google Scholar
• Touhami O, Grégoire J, Renaud M-C, et al. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia. Gynecol Oncol. 2018;148(3):485–490. doi: 10.1016/j.ygyno.2017.12.026
   PubMed Web of Science ®Google Scholar
• Matsuo K, Ramzan AA, Gualtieri MR, et al. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol. 2015;139(2):261–267. doi: 10.1016/j.ygyno.2015.07.108
   PubMed Web of Science ®Google Scholar
• Cuccu I, Raspagliesi F, Malzoni M, et al. Sentinel node mapping in high-intermediate and high-risk endometrial cancer: analysis of 5-year oncologic outcomes. Eur J Surg Oncol. 2024;50(4):108018. doi: 10.1016/j.ejso.2024.108018
   PubMed Web of Science ®Google Scholar
• Glaser G, Dinoi G, Multinu F, et al. Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer. Int J Gynecol Cancer. 2021;31(1):85–91. doi: 10.1136/ijgc-2020-001924
   PubMed Web of Science ®Google Scholar
• Carter J, Huang HQ, Armer J, et al. GOG 244 - the LymphEdema and gynecologic cancer (LEG) study: the association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE). Gynecol Oncol. 2019;155(3):452–460. doi: 10.1016/j.ygyno.2019.09.027
   PubMed Web of Science ®Google Scholar
• Mathevet P, Lécuru F, Uzan C, et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2). Eur J Cancer. 2021;148:307–315. doi: 10.1016/j.ejca.2021.02.009
   PubMedGoogle Scholar
• Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at memorial sloan-kettering cancer center. Gynecol Oncol. 2006;103(2):714–718. doi: 10.1016/j.ygyno.2006.03.055
   PubMed Web of Science ®Google Scholar
• Capozzi VA, Riemma G, Rosati A, et al. Surgical complications occurring during minimally invasive sentinel lymph node detection in endometrial cancer patients. A systematic review of the literature and metanalysis. Eur J Surg Oncol. 2021;47(8):2142–2149. doi: 10.1016/j.ejso.2021.03.253
   PubMed Web of Science ®Google Scholar
• Emerson J, Glassman D, Quddus MR, et al. Is sentinel lymph node sampling indicated in endometrial intraepithelial neoplasia? [37F]. Obstet & Gynecol. 2019;133(1):72S. doi: 10.1097/01.AOG.0000559068.92583.66
   Google Scholar
• Whyte JS, Gurney EP, Curtin JP, et al. Lymph node dissection in the surgical management of atypical endometrial hyperplasia. Am J Obstet Gynecol. 2010;202(2):176.e1–4. doi: 10.1016/j.ajog.2009.10.855
   PubMed Web of Science ®Google Scholar
• Bjørnholt SM, Sponholtz SE, Mogensen O, et al. The SENTIREC-endo study - risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer. Gynecol Oncol. 2023;171:121–128. doi: 10.1016/j.ygyno.2023.02.013
   PubMed Web of Science ®Google Scholar
• ACGME program requirements for graduate medical education in gynecologic oncology [Internet]. [cited 2024 Jan 29]. Available from: https://www.acgme.org/globalassets/pfassets/programrequirements/225_gynecologiconcology_2023.pdf
   Google Scholar
• Hoffman MS, Chi DS, Clarke-Pearson DL, et al. Surgical training in gynecologic oncology: past, present, future. Gynecol Oncol. 2020;158(1):188–193. doi: 10.1016/j.ygyno.2020.05.006
   PubMed Web of Science ®Google Scholar
• Lim SL, Moss HA, Secord AA, et al. Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: a cost-effectiveness analysis. Gynecol Oncol. 2018;151(3):506–512. doi: 10.1016/j.ygyno.2018.09.020
   PubMed Web of Science ®Google Scholar
• Vetter MH, Smith B, Benedict J, et al. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Am J Obstet Gynecol. 2020;222(1):.e60.1–.e60.7. doi: 10.1016/j.ajog.2019.08.002
   Web of Science ®Google Scholar
• Abt D, Macharia A, Hacker MR, et al. Endometrial stripe thickness: a preoperative marker to identify patients with endometrial intraepithelial neoplasia who may benefit from sentinel lymph node mapping and biopsy. Int J Gynecol Cancer [Internet]. 2022;32(9):1091–1097. Available from: https://ijgc.bmj.com/content/32/9/1091.abstract
   Web of Science ®Google Scholar
• Berg A, Hoivik EA, Mjøs S, et al. Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. Oncotarget. 2015;6(2):1327–1339. doi: 10.18632/oncotarget.2675
   PubMed Web of Science ®Google Scholar
• Levine DA, The Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73. doi: 10.1038/nature12113
   PubMed Web of Science ®Google Scholar
• Berek JS, Matias-Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer. Int J Gynaecol Obstet. 2023;162(2):383–394. doi: 10.1002/ijgo.14923
   PubMed Web of Science ®Google Scholar
• Raffone A, Catena U, Travaglino A, et al. Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: a multi-center study. Gynecol Oncol. 2021;161(3):795–801. doi: 10.1016/j.ygyno.2021.03.029
   PubMed Web of Science ®Google Scholar
• Puechl AM, Spinosa D, Berchuck A, et al. Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia. Cancers [Internet]. 2021;13. Available from: http://dx.doi.org/10.3390/cancers13112847
   Google Scholar